Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC - Archive ouverte HAL Access content directly
Journal Articles Lung Cancer Year : 2021

Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC

(1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (1) , (2) , (1) , (3, 4, 1) , (1) , (1) , (1)
1
2
3
4

Dates and versions

hal-03689919 , version 1 (07-06-2022)

Identifiers

Cite

Nanruoyi Zhou, Maria Velez, Benjamin Bachrach, Jaklin Gukasyan, Charlene Fares, et al.. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event post-treatment in NSCLC. Lung Cancer, 2021, 161, pp.34-41. ⟨10.1016/j.lungcan.2021.08.009⟩. ⟨hal-03689919⟩
4 View
0 Download

Altmetric

Share

Gmail Facebook Twitter LinkedIn More